Gary Levy

18.7k total citations
377 papers, 14.1k citations indexed

About

Gary Levy is a scholar working on Hepatology, Surgery and Epidemiology. According to data from OpenAlex, Gary Levy has authored 377 papers receiving a total of 14.1k indexed citations (citations by other indexed papers that have themselves been cited), including 146 papers in Hepatology, 131 papers in Surgery and 88 papers in Epidemiology. Recurrent topics in Gary Levy's work include Organ Transplantation Techniques and Outcomes (108 papers), Liver Disease and Transplantation (89 papers) and Renal Transplantation Outcomes and Treatments (67 papers). Gary Levy is often cited by papers focused on Organ Transplantation Techniques and Outcomes (108 papers), Liver Disease and Transplantation (89 papers) and Renal Transplantation Outcomes and Treatments (67 papers). Gary Levy collaborates with scholars based in Canada, United States and France. Gary Levy's co-authors include Paul D. Greig, David Grant, Mark S. Cattral, Ian D. McGilvray, Julian L. Leibowitz, T S Edgington, A. E. Johnston, David A. Clark, L. S. Fung and Edward Cole and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Gary Levy

368 papers receiving 13.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gary Levy Canada	67	5.3k	4.5k	4.1k	2.5k	2.2k	377	14.1k
Lionel Rostaing France	72	7.3k 1.4×	4.8k 1.1×	5.3k 1.3×	2.3k 0.9×	8.6k 3.8×	591	20.2k
Björn Nashan Germany	55	2.7k 0.5×	5.3k 1.2×	2.7k 0.7×	1.5k 0.6×	5.9k 2.6×	377	12.8k
Andreas G. Tzakis United States	74	8.8k 1.7×	14.2k 3.2×	5.3k 1.3×	1.5k 0.6×	7.6k 3.4×	656	23.4k
Manuel Pascual Switzerland	53	1.4k 0.3×	3.3k 0.7×	2.7k 0.7×	2.2k 0.9×	4.3k 1.9×	266	10.6k
Christophe Legendre France	76	1.4k 0.3×	5.1k 1.2×	3.6k 0.9×	3.6k 1.4×	9.1k 4.0×	426	18.5k
Étienne Sokal Belgium	67	6.5k 1.2×	7.0k 1.6×	5.0k 1.2×	773 0.3×	685 0.3×	420	15.2k
Herold J. Metselaar Netherlands	49	3.3k 0.6×	2.9k 0.7×	2.1k 0.5×	1.2k 0.5×	1.4k 0.6×	250	7.8k
Geoffrey W. McCaughan Australia	73	8.7k 1.6×	5.2k 1.2×	8.4k 2.0×	3.4k 1.3×	1.3k 0.6×	528	20.3k
David Grant Canada	61	6.4k 1.2×	8.0k 1.8×	2.5k 0.6×	906 0.4×	2.1k 0.9×	343	12.9k
Douglas G. Farmer United States	60	6.5k 1.2×	6.9k 1.5×	3.3k 0.8×	577 0.2×	1.7k 0.8×	234	11.1k

Countries citing papers authored by Gary Levy

Since Specialization

Citations

This map shows the geographic impact of Gary Levy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary Levy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary Levy more than expected).

Fields of papers citing papers by Gary Levy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary Levy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary Levy. The network helps show where Gary Levy may publish in the future.

Co-authorship network of co-authors of Gary Levy

This figure shows the co-authorship network connecting the top 25 collaborators of Gary Levy. A scholar is included among the top collaborators of Gary Levy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary Levy. Gary Levy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Levy, Gary, et al.. (2024). The effectiveness of cervical mucus electrical impedance compared to basal body temperature to determine fertility window. SHILAP Revista de lepidopterología. 9(1). 20–20. 2 indexed citations

Sadozai, Hassan, Kaveh Farrokhi, Sajad Moshkelgosha, et al.. (2023). Congenic hematopoietic stem cell transplantation promotes survival of heart allografts in murine models of acute and chronic rejection. Clinical & Experimental Immunology. 213(1). 138–154.

Levy, Gary, et al.. (2022). Impact of Question Bank Use for In-Training Examination Preparation by OBGYN Residents – A Multicenter Study. Journal of surgical education. 79(3). 775–782. 3 indexed citations

Wang, Junhua, Dominique A. Vuitton, Norbert Müller, et al.. (2015). Deletion of Fibrinogen-like Protein 2 (FGL-2), a Novel CD4+ CD25+ Treg Effector Molecule, Leads to Improved Control of Echinococcus multilocularis Infection in Mice. PLoS neglected tropical diseases. 9(5). e0003755–e0003755. 41 indexed citations

Selzner, Nazia, David Grant, Itay Shalev, & Gary Levy. (2010). The immunosuppressive pipeline: Meeting unmet needs in liver transplantation. Liver Transplantation. 16(12). 1359–1372. 14 indexed citations

Selzner, Markus, Arash Kashfi, Mark S. Cattral, et al.. (2009). A Graft to Body Weight Ratio Less Than 0.8 Does Not Exclude Adult-to-Adult Right-Lobe Living Donor Liver Transplantation. Liver Transplantation. 15(12). 1776–1782. 90 indexed citations

Shalev, Itay, Kit Man Wong, Katharina Foerster, et al.. (2008). The novel CD4+CD25+ regulatory T cell effector molecule fibrinogen-like protein 2 contributes to the outcome of murine fulminant viral hepatitis #. Hepatology. 49(2). 387–397. 74 indexed citations

Liu, Mingfeng, Michael Mendicino, Qin Ning, et al.. (2006). Cytokine-Induced Hepatic Apoptosis Is Dependent on FGL2/Fibroleukin: The Role of Sp1/Sp3 and STAT1/PU.1 Composite cis Elements. The Journal of Immunology. 176(11). 7028–7038. 51 indexed citations

Tanaka, Kazuo, et al.. (2004). Comparison of cyclosporine microemulsion and tacrolimus in 39 recipients of living donor liver transplantation. American Journal of Transplantation. 4. 185–185. 2 indexed citations

10.

Ghanekar, Anand, Michael Mendicino, Hao Liu, et al.. (2004). Endothelial Induction of fgl2 Contributes to Thrombosis during Acute Vascular Xenograft Rejection. The Journal of Immunology. 172(9). 5693–5701. 84 indexed citations

11.

Marsden, Philip A., Qin Ning, L. S. Fung, et al.. (2003). The Fgl2/fibroleukin prothrombinase contributes to immunologically mediated thrombosis in experimental and human viral hepatitis. Journal of Clinical Investigation. 112(1). 58–66. 11 indexed citations

12.

Chan, Camie W., Matthew W. C. Chan, Mingfeng Liu, et al.. (2002). Kinetic Analysis of a Unique Direct Prothrombinase, fgl2 , and Identification of a Serine Residue Critical for the Prothrombinase Activity. The Journal of Immunology. 168(10). 5170–5177. 66 indexed citations

13.

Humar, Atul, G Malkan, George Moussa, et al.. (2000). Human Herpesvirus–6 Is Associated with Cytomegalovirus Reactivation in Liver Transplant Recipients. The Journal of Infectious Diseases. 181(4). 1450–1453. 90 indexed citations

14.

Clark, David A., et al.. (1998). Cutting Edge: Cytokine-Dependent Abortion in CBA × DBA/2 Mice Is Mediated by the Procoagulant fgl2 Prothombinase. The Journal of Immunology. 160(2). 545–549. 237 indexed citations

15.

Belyavskaya, Elena, et al.. (1998). Coronavirus MHV-3-Induced Apoptosis in Macrophages. Virology. 250(1). 41–49. 31 indexed citations

16.

Gorczynski, Reginald M., et al.. (1997). γδTCR+, type-2 cytokine produced by hybridoma cells produced in mice given portal vein pretransplant immunization and allogeneic grafts can increase graft survival on adoptive transfer. Transplantation Proceedings. 29(1-2). 865–866. 1 indexed citations

17.

Buschman, Ellen, Emil Skamene, Pierre J. Talbot, & Gary Levy. (1995). Corona- and related viruses : current concepts in molecular biology and pathogenesis. Plenum Press eBooks. 7 indexed citations

18.

Paul, Anand, Gary Levy, & Paul D. Greig. (1993). Balancing cyclosporine A nephrotoxicity and rejection late after adult liver transplantation.. PubMed. 25(4). 2664–5. 2 indexed citations

19.

Fung, L. S., Andrew R. Crow, M. J. Phillips, et al.. (1992). Monoclonal antiprothrombinase (3D4.3) prevents mortality from murine hepatitis virus (MHV-3) infection.. The Journal of Experimental Medicine. 176(3). 689–697. 66 indexed citations

20.

Levy, Gary, Julian L. Leibowitz, & T S Edgington. (1981). Induction of monocyte procoagulant activity by murine hepatitis virus type 3 parallels disease susceptibility in mice.. The Journal of Experimental Medicine. 154(4). 1150–1163. 123 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact